Amide compounds and use of the same
Abstract
An amide compound of the formula (I): wherein R is amino and the like, A is alkylene and the like, X is O, S and the like, M is arylene and the like, R 1 , R 2 , R 3 and R 4 are H, hydroxy and the like, R 5 is H, alkyl and the like, m is an integer of 0-6, R 6 is an optionally substituted aryl and the like, and R 7 is H, an optionally substituted alkyl and the like, a pharmaceutically acceptable acid addition salt thereof and a pharmaceutical containing same as an active ingredient. The amide compounds exhibit superior suppressive effects on cytokines directly or indirectly involved in inflammations, such as IL-8, IL-1, IL-6, TNF-α, GM-CSF and the like, and are useful for the prophylaxis and treatment of rheumatic diseases, arthritis due to gout and the like.
Claims
exact text as granted — not AI-modified1. An amide compound of the formula (I):
wherein:
R is a piperazinyl optionally substituted by lower alkyl, a piperidyl optionally substituted by lower alkyl or an amino
wherein amino is optionally substituted by lower alkyl;
A is a linear alkylene;
X is an oxygen atom, a sulfur atom, —NH—or—CH 2 —;
M is an arylene;
R 1 , R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, provided at least one of R′, R 1 , R 2 , R 3 and R 4 is not a hydrogen atom, a hydroxy, a halogen atom, or —O—CO—R 11 ″′ wherein R 11 ″′ is lower alkyl optionally substituted by a substituent selected from the group consisting of amino, acyloxy and benzyloxycarbonyl, or phenyl optionally substituted by lower alkyl;
R 5 is hydrogen atom;
m is 1;
R 6 is a phenyl and
R 7 is —COO—R 12″
wherein R 12 ″′ is hydrogen atom, aralkyl, adamantyl, cyclohexylideneamino,
cyclohexyl optionally substituted by lower alkyl, piperidyl optionally substituted by lower alkyl, or alkyl optionally substituted by a substituent selected from the group consisting of hydroxy, lower alkoxy, lower alkoxy lower alkoxy, lower alkoxycarbonyl, acyloxy, piperazinyl and amino optionally substituted by lower alkyl;
or a pharmaceutically acceptable acid addition salt thereof.
2. The amide compound of claim 1 , wherein H M is phenylene, or a pharmaceutically acceptable acid addition salt thereof.
3. The amide compound of claim 1 , wherein R 7 is —COO—R 12 ″″ wherein R 12 ″″ is lower alkyl, or cyclohexyl which is optionally substituted by lower alkyl, or a pharmaceutically acceptable acid addition salt thereof.
4. The amide compound of claim 1 , wherein X is an oxygen atom or —CH 2 —, or a pharmaceutically acceptable acid addition salt thereof.
5. The amide compound of claim 1 , wherein R 6 is phenyl and m is 1, or a pharmaceutically acceptable acid addition salt thereof.
6. The amide compound of claim 1 , wherein R 1 , R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom provided that at least one of R 1 , R 2 , R 3 and R 4 is not a hydrogen atom, hydroxy, a halogen atom, or —O—CO—R 11 ″″ wherein R 11 ″″ is lower alkyl or phenyl, or a pharmaceutically acceptable acid addition salt thereof.
7. A pharmaceutical composition comprising a pharmaceutically acceptable carrier; and the amide compound of any one of claims 1 to 6 or a pharmaceutically acceptable acid addition salt thereof.
8. A method for suppressing the production of cytokines, comprising administering to a patient in need thereof, an inflammatory cytokine production suppressor comprising an amide compound of any one of claims 1 to 6 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.
9. A method for treating or prophylaxis of inflammatory diseases, comprising administering to a patient in need thereof, an agent for treating or prophylaxis of inflammatory diseases comprising an amide compound of any one of claims 1 to 6 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.
10. An amide compound of formula:
or a pharmaceutically acceptable acid addition salt thereof.
11. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and the amide compound of claim 10 or a pharmaceutically acceptabe acid addition salt thereof.
12. A method of suppressing the production of cytokines, comprising administering to a patient in a need thereof, an inflammatory cytokine production suppressor comprising the amide compound of claim 10 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.
13. A method for treating or prophylaxis of inflammatory diseases, comprising administering to a patient in need thereof, an agent for treating or prophylaxis of inflammatory diseases comprising the amide compound of claim 10 or a pharmaceutically acceptable acid addition salt thereof as an active ingredient.
14. An amide compound of the formula:
15. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and the amide compound of claim 14 .
16. A method of suppressing the production of cytokines, comprising administering to a patient in need thereof, an inflammatory cytokine production suppressor comprising the amide compound of claim 14 .
17. A method for treating or prophylaxis of inflammatory diseases, comprising administering to a patient in need thereof, an agent for treating or prophylaxis of inflammatory diseases comprising the amide compound of claim 14 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.